| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
EVP &Chief Commercial Officer
1 company
Dreyer Scott serves as an EVP &Chief Commercial Officer at COLL. Across recent SEC filings that breaks down to 0 buys and 31 sells. Those positions are worth an estimated $2.9M at current prices.
Historically, Dreyer Scott's trades have earned a middling insider score of 54/100 across 16 rated trades. Over a 12-month horizon, 23.1% of those trades were profitable, with an average 12-month return of -12.0%.
The biggest single holding is COLL (~$2.9M) as EVP &Chief Commercial Officer. The recent filings there lean toward selling, a net 349,166 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Jan 14, 2020 | COLL Collegium Pharmaceutical, Inc | EVP &Chief Commercial Officer | Sell | 1,321 | $23.87 | $31,532.27 | -3.6% | |
| Jul 11, 2019 | COLL Collegium Pharmaceutical, Inc | EVP &Chief Commercial Officer | Sell | 2,857 | $12.31 | $35,169.67 | -7.0% |